05.24.22
Crown Laboratories has signed an accord to acquire then global, aesthetics-focused assets of medtech company Eclipse. The acquisition expands Crown's aesthetics' product portfolio and enhances its overall value proposition as a global leader in science-based aesthetic skin care solutions, according to Crown, which is based in Johnson City TN.
Eclipse, based in Dallas, was established in January 1993 as a specialty surgical supply company. It quickly became a successful privately held medical device company and one of the pioneers in the aesthetic market, launching several energy-based devices globally
"We pride ourselves on being at the forefront of today's aesthetics market by developing and delivering best-in-class medical technologies and products that are exceptionally safe and effective," said Jeff Bedard, President and CEO of Crown. "This strategic acquisition furthers Crown's mission to drive innovation and provide superior products and customer service to aesthetics providers around the world. Eclipse's excellent products will broaden our product line and customer base, domestically and internationally."
Crown's topical skincare business has also been expanding. In 2021, it acquired StriVectin. Last week, the company hired a new executive to run its premium skincare business.
Eclipse, based in Dallas, was established in January 1993 as a specialty surgical supply company. It quickly became a successful privately held medical device company and one of the pioneers in the aesthetic market, launching several energy-based devices globally
"We pride ourselves on being at the forefront of today's aesthetics market by developing and delivering best-in-class medical technologies and products that are exceptionally safe and effective," said Jeff Bedard, President and CEO of Crown. "This strategic acquisition furthers Crown's mission to drive innovation and provide superior products and customer service to aesthetics providers around the world. Eclipse's excellent products will broaden our product line and customer base, domestically and internationally."
Crown's topical skincare business has also been expanding. In 2021, it acquired StriVectin. Last week, the company hired a new executive to run its premium skincare business.